Recently, the group found that in chronic limb-threatening ischemia, blood flow to the muscles tends not to be reduced despite arterial blockages. On the contrary, blood flow can even increase due ...

The study analysed 124 patients who were admitted to UHL between March 2022 and March 2023 for surgical treatment for chronic ...

Persistent over-dilation of muscle microvasculature may be one cause of chronic limb-threatening ischemia, recent studies by Kuopio University Hospital and the University of Eastern Finland show. In ...

Cagent Vascular, Inc. announced the launch of its Serranator SL-Pro percutaneous transluminal angioplasty (PTA) serration ballo ...

AMBITION BTK is a multicenter, randomized controlled trial (RCT) designed to evaluate the clinical outcomes of the Auryon Atherectomy System in combination with standard balloon angioplasty compared ...

Aplagon, a clinical stage biopharmaceutical company developing a first-in-class therapeutic for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan mimetic with antiplatelet and ...

UK King’s Daughters became the first hospital in Kentucky — and the only hospital in the region — to offer a new minimally invasive procedure for ...

AngioDynamics initiates the AMBITION BTK RCT and registry to advance treatment for patients with chronic limb-threatening ischemia and below-the-knee peripheral artery disease.

Persistent over-dilation of muscle microvasculature may be one cause of chronic limb-threatening ischemia, recent studies by Kuopio University Hospital and the University of Eastern Finland show.